


Healthcare News Roundup: Biopharmaceutical
HSMN NewsFeed - 16 Oct 2006
IP Chemotherapy, Combination Therapy for Cervical Cancer and IVF Treatment for Infertility
IP Chemotherapy, Combination Therapy for Cervical Cancer and IVF Treatment for Infertility
HSMN NewsFeed - 16 Oct 2006
InfaCare Pharmaceutical Appoints Dr. Ronald Dundore, Vice President of Regulatory and Quality Affairs
InfaCare Pharmaceutical Appoints Dr. Ronald Dundore, Vice President of Regulatory and Quality Affairs
HSMN NewsFeed - 16 Oct 2006
Teva Announces OxyContin(R) Litigation Dismissed; Settlement with Purdue Finalized
Teva Announces OxyContin(R) Litigation Dismissed; Settlement with Purdue Finalized
HSMN NewsFeed - 16 Oct 2006
Zogenix Appoints J.D. Haldeman Vice President, Commercial Strategy & Corporate Communications
Zogenix Appoints J.D. Haldeman Vice President, Commercial Strategy & Corporate Communications
HSMN NewsFeed - 16 Oct 2006
Nabi Biopharmaceuticals Announces Positive Results From PhosLo(R) EPICK Study
Nabi Biopharmaceuticals Announces Positive Results From PhosLo(R) EPICK Study
HSMN NewsFeed - 16 Oct 2006
OMRIX Biopharmaceuticals Announces Positive Phase 3 Clinical Trial Results for Human Thrombin
OMRIX Biopharmaceuticals Announces Positive Phase 3 Clinical Trial Results for Human Thrombin
HSMN NewsFeed - 16 Oct 2006
Neurochem submits a complete response to FDA approvable letter for KIACTA(TM)
Neurochem submits a complete response to FDA approvable letter for KIACTA(TM)
HSMN NewsFeed - 16 Oct 2006
Ipsen and Tercica Complete Worldwide Strategic Collaboration Agreement in Endocrinology
Ipsen and Tercica Complete Worldwide Strategic Collaboration Agreement in Endocrinology
HSMN NewsFeed - 16 Oct 2006
Serono and Newron Announce Global Development and Commercialization Agreement for Safinamide
Serono and Newron Announce Global Development and Commercialization Agreement for Safinamide
HSMN NewsFeed - 13 Oct 2006
U.S. Food and Drug Administration Approves ARICEPT(R) for Treatment of Severe Alzheimer's Disease
U.S. Food and Drug Administration Approves ARICEPT(R) for Treatment of Severe Alzheimer's Disease
HSMN NewsFeed - 13 Oct 2006
Bayer Appoints Independent Investigator to Review Trasylol(R) Study Issues
Bayer Appoints Independent Investigator to Review Trasylol(R) Study Issues
HSMN NewsFeed - 13 Oct 2006
BioAlliance Pharma Receives Marketing Authorisation for Its First Product, Loramyc(R)
BioAlliance Pharma Receives Marketing Authorisation for Its First Product, Loramyc(R)
HSMN NewsFeed - 13 Oct 2006
Pfizer Names Senior Executive to Head Expanded Worldwide Licensing and Business Development
Pfizer Names Senior Executive to Head Expanded Worldwide Licensing and Business Development
HSMN NewsFeed - 13 Oct 2006
Neurotechnology Industry Organization Launched to Advance Treatments for Brain and Nervous System Illnesses
Neurotechnology Industry Organization Launched to Advance Treatments for Brain and Nervous System Illnesses
HSMN NewsFeed - 13 Oct 2006
BioMimetic Therapeutics Receives FDA Approval that Expands Manufacturing Capacity for GEM 21S(R)
BioMimetic Therapeutics Receives FDA Approval that Expands Manufacturing Capacity for GEM 21S(R)
HSMN NewsFeed - 13 Oct 2006
Merck & Co., Inc. and Lundbeck Announce Update in Submission Plans for U.S. Approval of Gaboxadol
Merck & Co., Inc. and Lundbeck Announce Update in Submission Plans for U.S. Approval of Gaboxadol
HSMN NewsFeed - 13 Oct 2006
Roche Advances Oral Polymerase Inhibitor into Phase II Study in Patients with Chronic Hepatitis C
Roche Advances Oral Polymerase Inhibitor into Phase II Study in Patients with Chronic Hepatitis C
HSMN NewsFeed - 12 Oct 2006
MGI PHARMA Receives Approvable Letter for Saforis(TM) (Glutamine) Powder in UpTec(TM) for Oral Suspension
MGI PHARMA Receives Approvable Letter for Saforis(TM) (Glutamine) Powder in UpTec(TM) for Oral Suspension
HSMN NewsFeed - 12 Oct 2006
EKR Therapeutics Acquires Exclusive License for Gelclair(R) from Helsinn Healthcare SA
EKR Therapeutics Acquires Exclusive License for Gelclair(R) from Helsinn Healthcare SA
HSMN NewsFeed - 12 Oct 2006
KaloBios Pharmaceuticals Appoints David W. Pritchard as President and Chief Executive Officer
KaloBios Pharmaceuticals Appoints David W. Pritchard as President and Chief Executive Officer
HSMN NewsFeed - 12 Oct 2006
Peregrine Receives Regulatory Approval for New Cotara(R) Brain Cancer Clinical Trial
Peregrine Receives Regulatory Approval for New Cotara(R) Brain Cancer Clinical Trial
HSMN NewsFeed - 12 Oct 2006
BioSante Pharmaceuticals Presents Bio-E-Gel(R) Woman-to-Partner Transfer Study at Menopause Society Meeting
BioSante Pharmaceuticals Presents Bio-E-Gel(R) Woman-to-Partner Transfer Study at Menopause Society Meeting
HSMN NewsFeed - 12 Oct 2006
Arrowhead Subsidiary, Insert Therapeutics, to Hire Pharmaceutical Executive as Chief Executive Officer
Arrowhead Subsidiary, Insert Therapeutics, to Hire Pharmaceutical Executive as Chief Executive Officer
HSMN NewsFeed - 12 Oct 2006
Newly Published Data Show Efficacy and Safety of LUNESTA(R) in Elderly Patients with Insomnia
Newly Published Data Show Efficacy and Safety of LUNESTA(R) in Elderly Patients with Insomnia
HSMN NewsFeed - 12 Oct 2006
Anesiva Announces That FDA Grants Orphan Drug Status for Pain Drug 4975 to Treat Interdigital Neuroma
Anesiva Announces That FDA Grants Orphan Drug Status for Pain Drug 4975 to Treat Interdigital Neuroma
HSMN NewsFeed - 12 Oct 2006
Nabi Biopharmaceuticals Signs Definitive Agreement To Sell PhosLo(R) To Fresenius Medical Care
Nabi Biopharmaceuticals Signs Definitive Agreement To Sell PhosLo(R) To Fresenius Medical Care
HSMN NewsFeed - 12 Oct 2006
Agennix Receives FDA Orphan Drug Designation for Talactoferrin Alfa in Renal Cell Carcinoma
Agennix Receives FDA Orphan Drug Designation for Talactoferrin Alfa in Renal Cell Carcinoma
HSMN NewsFeed - 12 Oct 2006
Favrille Appoints Former Eli Lilly Executive Michael Eagle Chairman of the Board
Favrille Appoints Former Eli Lilly Executive Michael Eagle Chairman of the Board
HSMN NewsFeed - 12 Oct 2006
Fresenius Medical Care to Acquire Phosphate Binder Business from Nabi Biopharmaceuticals
Fresenius Medical Care to Acquire Phosphate Binder Business from Nabi Biopharmaceuticals
HSMN NewsFeed - 12 Oct 2006
Over 70 Industry Experts to appear at forthcoming EyeforPharma Sales Force Effectiveness Summit
Over 70 Industry Experts to appear at forthcoming EyeforPharma Sales Force Effectiveness Summit
HSMN NewsFeed - 11 Oct 2006
Roche and Trimeris Provide Update on Development of Needle-Free Administration for FUZEON(R)
Roche and Trimeris Provide Update on Development of Needle-Free Administration for FUZEON(R)
HSMN NewsFeed - 11 Oct 2006
MAP Pharmaceuticals Appoints New Sr. Vice President of Corporate and Business Development
MAP Pharmaceuticals Appoints New Sr. Vice President of Corporate and Business Development
HSMN NewsFeed - 11 Oct 2006
CV Therapeutics Ending Co-Promotion of ACEON(R) (perindopril erbumine) Tablets
CV Therapeutics Ending Co-Promotion of ACEON(R) (perindopril erbumine) Tablets
HSMN NewsFeed - 11 Oct 2006
NitroMed Revises Sales and Marketing Strategy - Accelerates Development of Extended Release BiDil(R)
NitroMed Revises Sales and Marketing Strategy - Accelerates Development of Extended Release BiDil(R)
HSMN NewsFeed - 10 Oct 2006
Hi-Tech Pharmacal Announces the Hiring of Eyal Mares as Vice President, Operations
Hi-Tech Pharmacal Announces the Hiring of Eyal Mares as Vice President, Operations
HSMN NewsFeed - 10 Oct 2006
Genzyme Announces Proposal to Increase Its Offer to Acquire AnorMED to $13.50 Per Share in Cash
Genzyme Announces Proposal to Increase Its Offer to Acquire AnorMED to $13.50 Per Share in Cash
HSMN NewsFeed - 10 Oct 2006
Corautus Genetics Announces Final Efficacy Results of GENASIS Phase IIb Clinical Trial
Corautus Genetics Announces Final Efficacy Results of GENASIS Phase IIb Clinical Trial
HSMN NewsFeed - 10 Oct 2006
GeoPharma Announces Schering-Plough Lawsuit Related to Generic Version of Clarinex(R)
GeoPharma Announces Schering-Plough Lawsuit Related to Generic Version of Clarinex(R)
HSMN NewsFeed - 10 Oct 2006
MacroGenics Receives Orphan Drug Designation From FDA for Monoclonal Antibody to Treat Type 1 Diabetes
MacroGenics Receives Orphan Drug Designation From FDA for Monoclonal Antibody to Treat Type 1 Diabetes
HSMN NewsFeed - 10 Oct 2006
Triax Pharmaceuticals Announces the Launch of MINOCIN(R) (minocycline HCl) Professional Acne Care (PAC)
Triax Pharmaceuticals Announces the Launch of MINOCIN(R) (minocycline HCl) Professional Acne Care (PAC)
HSMN NewsFeed - 10 Oct 2006
Dr. Reddy's Announces Settlement of Imitrex(R) Litigation with GlaxoSmithKline
Dr. Reddy's Announces Settlement of Imitrex(R) Litigation with GlaxoSmithKline
HSMN NewsFeed - 9 Oct 2006
GenVec Names Mark O. Thornton, MD, MPH, PhD as Senior Vice President, Clinical Development
GenVec Names Mark O. Thornton, MD, MPH, PhD as Senior Vice President, Clinical Development
HSMN NewsFeed - 8 Oct 2006
Eisai Receives Summary Judgment Motion Decisions in U.S. Legal Action Over Aciphex(R) ANDA Filings
Eisai Receives Summary Judgment Motion Decisions in U.S. Legal Action Over Aciphex(R) ANDA Filings
HSMN NewsFeed - 6 Oct 2006
FDA Approves RISPERDAL(R) for Treatment of Irritability Associated with Autistic Disorder
FDA Approves RISPERDAL(R) for Treatment of Irritability Associated with Autistic Disorder
HSMN NewsFeed - 6 Oct 2006
Wyeth Submits NDA and MAA for Torisel for the Treatment of Advanced Renal Cell Carcinoma
Wyeth Submits NDA and MAA for Torisel for the Treatment of Advanced Renal Cell Carcinoma
HSMN NewsFeed - 6 Oct 2006
SUBOXONE(R) (Buprenorphine/Naloxone) Approved In European Union for Treatment of Opioid Dependence
SUBOXONE(R) (Buprenorphine/Naloxone) Approved In European Union for Treatment of Opioid Dependence
HSMN NewsFeed - 5 Oct 2006
Oscient Pharmaceuticals and Pfizer, S.A. de C.V. Announce Launch of FACTIVE(R) Tablets in Mexico
Oscient Pharmaceuticals and Pfizer, S.A. de C.V. Announce Launch of FACTIVE(R) Tablets in Mexico
HSMN NewsFeed - 5 Oct 2006
GSK's New Flu Vaccine, FluLaval(TM), Provides Americans With a New Option for Fighting the Flu
GSK's New Flu Vaccine, FluLaval(TM), Provides Americans With a New Option for Fighting the Flu
HSMN NewsFeed - 5 Oct 2006
Biotica Enters into a Research and License Agreement with Wyeth for Novel Rapamycin Analogs
Biotica Enters into a Research and License Agreement with Wyeth for Novel Rapamycin Analogs
HSMN NewsFeed - 4 Oct 2006
Genentech Announces Vice President Appointments in Commercial Operations and Manufacturing
Genentech Announces Vice President Appointments in Commercial Operations and Manufacturing
HSMN NewsFeed - 4 Oct 2006
NEW ENGLAND JOURNAL OF MEDICINE Reports Positive Results From Dynavax' Ragweed Allergy Therapy Trial
NEW ENGLAND JOURNAL OF MEDICINE Reports Positive Results From Dynavax' Ragweed Allergy Therapy Trial
HSMN NewsFeed - 4 Oct 2006
Plexxikon and Roche Enter Partnership to Develop Targeted Cancer Therapeutic Medicine PLX4032
Plexxikon and Roche Enter Partnership to Develop Targeted Cancer Therapeutic Medicine PLX4032
HSMN NewsFeed - 4 Oct 2006
Antares Pharma to Supply Teva with Innovative Needle-Free Injection System
Antares Pharma to Supply Teva with Innovative Needle-Free Injection System
HSMN NewsFeed - 4 Oct 2006
Arixtra(R) Receives Priority Review by the FDA in Acute Coronary Syndromes (ACS)
Arixtra(R) Receives Priority Review by the FDA in Acute Coronary Syndromes (ACS)
HSMN NewsFeed - 3 Oct 2006
Dr. Garen Manvelian Joins New River Pharmaceuticals as Chief Medical Officer
Dr. Garen Manvelian Joins New River Pharmaceuticals as Chief Medical Officer
HSMN NewsFeed - 3 Oct 2006
Transport Pharmaceuticals Hires Vice President of Quality Systems and Operational Excellence
Transport Pharmaceuticals Hires Vice President of Quality Systems and Operational Excellence
HSMN NewsFeed - 3 Oct 2006
Allos Therapeutics Receives FDA Fast Track Designation for PDX for the Treatment of T-cell Lymphoma
Allos Therapeutics Receives FDA Fast Track Designation for PDX for the Treatment of T-cell Lymphoma
HSMN NewsFeed - 3 Oct 2006
Baxter Announces Sale of Transfusion Therapies Business to Texas Pacific Group
Baxter Announces Sale of Transfusion Therapies Business to Texas Pacific Group
HSMN NewsFeed - 3 Oct 2006
AEterna Zentaris Announces Positive Phase 2 Results for Ozarelix in Benign Prostatic Hyperplasia
AEterna Zentaris Announces Positive Phase 2 Results for Ozarelix in Benign Prostatic Hyperplasia
HSMN NewsFeed - 3 Oct 2006
Archemix Strengthens Management With Appointment of James Gilbert, M.D., as Chief Medical Officer
Archemix Strengthens Management With Appointment of James Gilbert, M.D., as Chief Medical Officer
HSMN NewsFeed - 3 Oct 2006
Regeneron Names Peter Powchik, M.D., Senior Vice President of Clinical Development
Regeneron Names Peter Powchik, M.D., Senior Vice President of Clinical Development
HSMN NewsFeed - 2 Oct 2006
Ipsen: EMEA's Validation of Febuxostat's Marketing Authorization Application in the European Union
Ipsen: EMEA's Validation of Febuxostat's Marketing Authorization Application in the European Union
HSMN NewsFeed - 2 Oct 2006
Genzyme Receives European Approval for Synvisc(R) In Ankle and Shoulder Osteoarthritis Indications
Genzyme Receives European Approval for Synvisc(R) In Ankle and Shoulder Osteoarthritis Indications
HSMN NewsFeed - 2 Oct 2006
John Ratliff Appointed Chief Operating Officer of Quintiles Transnational Corp.
John Ratliff Appointed Chief Operating Officer of Quintiles Transnational Corp.
HSMN NewsFeed - 2 Oct 2006
COPAXONE(R) Showed Sustained Benefit on Slowing Brain Tissue Damage in Multiple Sclerosis Patients
COPAXONE(R) Showed Sustained Benefit on Slowing Brain Tissue Damage in Multiple Sclerosis Patients
HSMN NewsFeed - 2 Oct 2006
PowderMed to Conduct U.S. Clinical Trial of DNA-Based Annual Influenza Vaccine
PowderMed to Conduct U.S. Clinical Trial of DNA-Based Annual Influenza Vaccine
HSMN NewsFeed - 29 Sep 2006
FDA Approves Two New Indications for Rituxan(R) in Patients With Non-Hodgkin's Lymphoma
FDA Approves Two New Indications for Rituxan(R) in Patients With Non-Hodgkin's Lymphoma
HSMN NewsFeed - 29 Sep 2006
FDA Issues Approvable Letter for Paliperidone ER for the Treatment of Schizophrenia
FDA Issues Approvable Letter for Paliperidone ER for the Treatment of Schizophrenia
HSMN NewsFeed - 29 Sep 2006
Mathematical Model Predicts That CERVARIX May Prevent Nearly 80 Percent of Cervical Cancers
Mathematical Model Predicts That CERVARIX May Prevent Nearly 80 Percent of Cervical Cancers
HSMN NewsFeed - 29 Sep 2006
Celsion Obtains from Valentis Exclusive Rights to Pegylation Patents for use with Heat Activated Liposomes
Celsion Obtains from Valentis Exclusive Rights to Pegylation Patents for use with Heat Activated Liposomes
HSMN NewsFeed - 29 Sep 2006
AVONEX(R), the #1 Prescribed Multiple Sclerosis (MS) Therapy Worldwide: New MRI Data Presented
AVONEX(R), the #1 Prescribed Multiple Sclerosis (MS) Therapy Worldwide: New MRI Data Presented
HSMN NewsFeed - 29 Sep 2006
Amgen to Acquire Avidia, a Privately Held Biopharmaceutical Company in the San Francisco Bay Area
Amgen to Acquire Avidia, a Privately Held Biopharmaceutical Company in the San Francisco Bay Area
HSMN NewsFeed - 29 Sep 2006
OMRIX Biopharmaceuticals Announces New Strategic Product Development Programs
OMRIX Biopharmaceuticals Announces New Strategic Product Development Programs
HSMN NewsFeed - 29 Sep 2006
Published Data Show Kereos Technology Specifically Targets Arterial Plaque
Published Data Show Kereos Technology Specifically Targets Arterial Plaque
HSMN NewsFeed - 28 Sep 2006
INEX Updates Timeline for Completing Spin-out of Tekmira Pharmaceuticals Corporation
INEX Updates Timeline for Completing Spin-out of Tekmira Pharmaceuticals Corporation
HSMN NewsFeed - 28 Sep 2006
New Data Reinforce Efficacy of TRIZIVIR(R) Alone in Treatment-Naive HIV Patients with Low Viral Load
New Data Reinforce Efficacy of TRIZIVIR(R) Alone in Treatment-Naive HIV Patients with Low Viral Load
HSMN NewsFeed - 28 Sep 2006
United States Seeing Greater Increases in Clostridium Difficile-Associated Disease Case-Load and Severity
United States Seeing Greater Increases in Clostridium Difficile-Associated Disease Case-Load and Severity
HSMN NewsFeed - 28 Sep 2006
ImClone Systems Promotes Ana I. Stancic to Senior Vice President, Finance
ImClone Systems Promotes Ana I. Stancic to Senior Vice President, Finance
HSMN NewsFeed - 28 Sep 2006
ViroPharma Initiates First of Two Phase 3 Studies of Maribavir in Transplant Patients
ViroPharma Initiates First of Two Phase 3 Studies of Maribavir in Transplant Patients
HSMN NewsFeed - 28 Sep 2006
Wyeth Announces the Election of Raymond J. McGuire to Its Board of Directors
Wyeth Announces the Election of Raymond J. McGuire to Its Board of Directors
HSMN NewsFeed - 28 Sep 2006
Caremark Appoints Jack E. Bruner as Executive Vice President of Marketing
Caremark Appoints Jack E. Bruner as Executive Vice President of Marketing
HSMN NewsFeed - 28 Sep 2006
Advancis Pharmaceutical Receives Judgment in Trademark Infringement Lawsuit
Advancis Pharmaceutical Receives Judgment in Trademark Infringement Lawsuit
HSMN NewsFeed - 28 Sep 2006
NovaDel Announces Positive Results from Pharmacokinetic Study of Improved Sumatriptan Oral Spray Formulation
NovaDel Announces Positive Results from Pharmacokinetic Study of Improved Sumatriptan Oral Spray Formulation
HSMN NewsFeed - 28 Sep 2006
Cerimon Pharmaceuticals Names Timothy J. McBride as Senior Vice President of Business Development
Cerimon Pharmaceuticals Names Timothy J. McBride as Senior Vice President of Business Development
HSMN NewsFeed - 28 Sep 2006
Medivation Receives FDA Permission to Begin Dimebon Huntington's Disease Trial
Medivation Receives FDA Permission to Begin Dimebon Huntington's Disease Trial
HSMN NewsFeed - 27 Sep 2006
FDA Approves Vectibix(TM) to Treat Patients with Metastatic Colorectal Cancer
FDA Approves Vectibix(TM) to Treat Patients with Metastatic Colorectal Cancer
HSMN NewsFeed - 27 Sep 2006
BASi Announces Reorganization of Operations: Adds Interim Chief Executive Officer
BASi Announces Reorganization of Operations: Adds Interim Chief Executive Officer
HSMN NewsFeed - 27 Sep 2006
Dr. Robert C. Moellering, Jr. Joins NanoBio Corporation's Board of Directors
Dr. Robert C. Moellering, Jr. Joins NanoBio Corporation's Board of Directors
HSMN NewsFeed - 27 Sep 2006
Cenix BioScience and Merck KGaA Sign Framework Agreement for RNAi-Based Drug Discovery
Cenix BioScience and Merck KGaA Sign Framework Agreement for RNAi-Based Drug Discovery
HSMN NewsFeed - 27 Sep 2006
Merck and FoxHollow Technologies Expand Scope of Worldwide Strategic Research Collaboration
Merck and FoxHollow Technologies Expand Scope of Worldwide Strategic Research Collaboration
HSMN NewsFeed - 27 Sep 2006
La Jolla Pharmaceutical Provides Update on Phase 3 International Riquent(R) Study
La Jolla Pharmaceutical Provides Update on Phase 3 International Riquent(R) Study
HSMN NewsFeed - 27 Sep 2006
Avalon Pharmaceuticals Appoints David D. Muth to Executive Vice President, Chief Business Officer
Avalon Pharmaceuticals Appoints David D. Muth to Executive Vice President, Chief Business Officer
HSMN NewsFeed - 27 Sep 2006
Final data from Antisoma's AS1404 lung cancer trial show clear survival benefit
Final data from Antisoma's AS1404 lung cancer trial show clear survival benefit
HSMN NewsFeed - 26 Sep 2006
Patrick G. LePore Named President and Chief Executive Officer of Par Pharmaceutical Companies, Inc.
Patrick G. LePore Named President and Chief Executive Officer of Par Pharmaceutical Companies, Inc.
HSMN NewsFeed - 26 Sep 2006
Third Point LLC Announces Consent Solicitation to Remove Nabi Biopharmaceuticals Board Chairman
Third Point LLC Announces Consent Solicitation to Remove Nabi Biopharmaceuticals Board Chairman
HSMN NewsFeed - 26 Sep 2006
Savient Pharmaceuticals Files Patent Infringement Lawsuit Against Barr Laboratories Inc.
Savient Pharmaceuticals Files Patent Infringement Lawsuit Against Barr Laboratories Inc.
HSMN NewsFeed - 26 Sep 2006
Millennium Agrees to Acquire AnorMED, Adding Phase III Oncology Product with Planned Near Term Launch Date
Millennium Agrees to Acquire AnorMED, Adding Phase III Oncology Product with Planned Near Term Launch Date
HSMN NewsFeed - 26 Sep 2006
ProNAi Announces Executive Team Buildup, Names New CEO and Top Development Management
ProNAi Announces Executive Team Buildup, Names New CEO and Top Development Management
HSMN NewsFeed - 26 Sep 2006
Callisto Pharmaceuticals Granted Orphan Drug Designation for Atiprimod to Treat Carcinoid Tumors
Callisto Pharmaceuticals Granted Orphan Drug Designation for Atiprimod to Treat Carcinoid Tumors
HSMN NewsFeed - 26 Sep 2006
PDI, Inc. Comments on Status of GlaxoSmithKline Fee for Service Contract Sales Program
PDI, Inc. Comments on Status of GlaxoSmithKline Fee for Service Contract Sales Program
HSMN NewsFeed - 26 Sep 2006
CutisPharma Launches 25 mg Strength in Progesterone Vaginal Suppository Product Line
CutisPharma Launches 25 mg Strength in Progesterone Vaginal Suppository Product Line
HSMN NewsFeed - 26 Sep 2006
Pfizer Expands Research Commitment to Ophthalmology Through Licensing Agreement With Quark Biotech
Pfizer Expands Research Commitment to Ophthalmology Through Licensing Agreement With Quark Biotech
HSMN NewsFeed - 26 Sep 2006
Allergan, Inc. Announces Launch of JUVEDERM(TM) ULTRA and JUVEDERM(TM) ULTRA PLUS
Allergan, Inc. Announces Launch of JUVEDERM(TM) ULTRA and JUVEDERM(TM) ULTRA PLUS
HSMN NewsFeed - 25 Sep 2006
Arena Pharmaceuticals Announces Update on Partnership With Merck in Development of Niacin Receptor Agonists
Arena Pharmaceuticals Announces Update on Partnership With Merck in Development of Niacin Receptor Agonists
HSMN NewsFeed - 25 Sep 2006
sanofi-aventis and UCB Sign a Co-Promotion Agreement for Xyzal(R) in the United States
sanofi-aventis and UCB Sign a Co-Promotion Agreement for Xyzal(R) in the United States
HSMN NewsFeed - 25 Sep 2006
UCB and sanofi-aventis sign a co-promotion agreement for Xyzal(R) in the United States
UCB and sanofi-aventis sign a co-promotion agreement for Xyzal(R) in the United States
HSMN NewsFeed - 25 Sep 2006
Approval of FOSRENOL in the United Kingdom triggers U.S.$3 million payment to AnorMED
Approval of FOSRENOL in the United Kingdom triggers U.S.$3 million payment to AnorMED
HSMN NewsFeed - 22 Sep 2006
European Commission Approves GARDASIL(R), Merck's Cervical Cancer Vaccine
European Commission Approves GARDASIL(R), Merck's Cervical Cancer Vaccine
HSMN NewsFeed - 22 Sep 2006
Merck and Nicaragua Unveil New Rotavirus Vaccine Demonstration Project at Clinton Global Initiative
Merck and Nicaragua Unveil New Rotavirus Vaccine Demonstration Project at Clinton Global Initiative
HSMN NewsFeed - 22 Sep 2006
ZIOPHARM Appoints John Amedio, Ph.D. as Vice President, Manufacturing & Process Development
ZIOPHARM Appoints John Amedio, Ph.D. as Vice President, Manufacturing & Process Development
HSMN NewsFeed - 22 Sep 2006
DOR BioPharma Files New Drug Application with FDA to Market orBec for GI GVHD
DOR BioPharma Files New Drug Application with FDA to Market orBec for GI GVHD
HSMN NewsFeed - 21 Sep 2006
Alcon's TRAVATAN(R) Z Solution Approved by FDA for Treatment of Glaucoma and Ocular Hypertensive Patients
Alcon's TRAVATAN(R) Z Solution Approved by FDA for Treatment of Glaucoma and Ocular Hypertensive Patients
HSMN NewsFeed - 21 Sep 2006
FDA Advisory Committee Strongly Endorses Use of Trasylol(R) in CABG Surgery Patients
FDA Advisory Committee Strongly Endorses Use of Trasylol(R) in CABG Surgery Patients
HSMN NewsFeed - 21 Sep 2006
Ranbaxy Receives Approval to Commercialize Furosemide Tablets in the U.S.
Ranbaxy Receives Approval to Commercialize Furosemide Tablets in the U.S.
HSMN NewsFeed - 21 Sep 2006
Latest Data Confirm Benefits of Evoltra(R) in Children with Relapsed/Refractory Acute Leukemia
Latest Data Confirm Benefits of Evoltra(R) in Children with Relapsed/Refractory Acute Leukemia
HSMN NewsFeed - 21 Sep 2006
Shareholders of Inex Pharmaceuticals Approve Spin Out of Tekmira Pharmaceuticals Corporation
Shareholders of Inex Pharmaceuticals Approve Spin Out of Tekmira Pharmaceuticals Corporation
HSMN NewsFeed - 21 Sep 2006
Medivation's Dimebon Meets All Five Efficacy Endpoints in Phase 2 Alzheimer's Disease Study
Medivation's Dimebon Meets All Five Efficacy Endpoints in Phase 2 Alzheimer's Disease Study
HSMN NewsFeed - 21 Sep 2006
OSI Pharmaceuticals Launches Study of Tarceva(R) as Adjuvant Treatment for Non-Small Cell Lung Cancer
OSI Pharmaceuticals Launches Study of Tarceva(R) as Adjuvant Treatment for Non-Small Cell Lung Cancer
HSMN NewsFeed - 21 Sep 2006
Serono's Oral Cladribine for the Treatment of Multiple Sclerosis Awarded Fast Track Status by FDA
Serono's Oral Cladribine for the Treatment of Multiple Sclerosis Awarded Fast Track Status by FDA
HSMN NewsFeed - 20 Sep 2006
Amgen Names Thomas Flanagan Senior Vice President and Chief Information Officer
Amgen Names Thomas Flanagan Senior Vice President and Chief Information Officer
HSMN NewsFeed - 20 Sep 2006
Acusphere Hires Jonathan Jaffe, M.D. in Newly Created Position of Vice President Medical Affairs
Acusphere Hires Jonathan Jaffe, M.D. in Newly Created Position of Vice President Medical Affairs
HSMN NewsFeed - 20 Sep 2006
ProEthic Pharmaceuticals Promotes Roger Graben to Vice President, Business Development
ProEthic Pharmaceuticals Promotes Roger Graben to Vice President, Business Development
HSMN NewsFeed - 20 Sep 2006
British Journal of Haematology Publishes Thrombosis Findings From ASCENT Trial
British Journal of Haematology Publishes Thrombosis Findings From ASCENT Trial
HSMN NewsFeed - 19 Sep 2006
FDA Approves Connetics' Verdeso Foam for the Treatment of Mild-to-Moderate Atopic Dermatitis
FDA Approves Connetics' Verdeso Foam for the Treatment of Mild-to-Moderate Atopic Dermatitis
HSMN NewsFeed - 19 Sep 2006
Amgen Announces License Agreement with Yeda Research and Development Company Ltd.
Amgen Announces License Agreement with Yeda Research and Development Company Ltd.
HSMN NewsFeed - 19 Sep 2006
PhytoMedical Announces Appointment of Senior Pharmaceutical Executives to Board of Directors
PhytoMedical Announces Appointment of Senior Pharmaceutical Executives to Board of Directors
HSMN NewsFeed - 19 Sep 2006
Lorus Therapeutics announces that Dr. Jim A. Wright will step down as President and Chief Executive Officer
Lorus Therapeutics announces that Dr. Jim A. Wright will step down as President and Chief Executive Officer
HSMN NewsFeed - 19 Sep 2006
Lorus Therapeutics announces the appointment of a new President and Chief Executive Officer
Lorus Therapeutics announces the appointment of a new President and Chief Executive Officer
HSMN NewsFeed - 19 Sep 2006
Dermik Laboratories Announces FDA Acceptance of Supplemental Filing Application for Sculptra(R)
Dermik Laboratories Announces FDA Acceptance of Supplemental Filing Application for Sculptra(R)
HSMN NewsFeed - 19 Sep 2006
Cancer Patients Show Reduced Pain and Lower Analgesic Consumption Following Treatment with QUADRAMET(R)
Cancer Patients Show Reduced Pain and Lower Analgesic Consumption Following Treatment with QUADRAMET(R)
HSMN NewsFeed - 19 Sep 2006
ImClone Systems Issues Statement on Court Ruling in Litigation against Yeda
ImClone Systems Issues Statement on Court Ruling in Litigation against Yeda
HSMN NewsFeed - 18 Sep 2006
Alcon Licenses Novel Anti-Infective Compounds for Eye, Ear and Sinus Infections from NovaCal
Alcon Licenses Novel Anti-Infective Compounds for Eye, Ear and Sinus Infections from NovaCal
HSMN NewsFeed - 18 Sep 2006
NovaCal Licenses Novel Anti-Infective Compounds for Eye, Ear and Sinus Infections to Alcon
NovaCal Licenses Novel Anti-Infective Compounds for Eye, Ear and Sinus Infections to Alcon
HSMN NewsFeed - 18 Sep 2006
U.S. Court of Appeals Denies Rehearing Request in Dismissal of Tamoxifen Citrate Antitrust Lawsuits
U.S. Court of Appeals Denies Rehearing Request in Dismissal of Tamoxifen Citrate Antitrust Lawsuits
HSMN NewsFeed - 18 Sep 2006
Bausch & Lomb Licenses SEGRA Compound From Schering AG for Ophthalmic Use
Bausch & Lomb Licenses SEGRA Compound From Schering AG for Ophthalmic Use
HSMN NewsFeed - 17 Sep 2006
Women More Likely to Stay on Once-Monthly Boniva(R) Versus Once-Weekly Osteoporosis Medicines
Women More Likely to Stay on Once-Monthly Boniva(R) Versus Once-Weekly Osteoporosis Medicines
HSMN NewsFeed - 15 Sep 2006
Final Report of Genasense Phase 3 Trial in Melanoma Published in Journal of Clinical Oncology
Final Report of Genasense Phase 3 Trial in Melanoma Published in Journal of Clinical Oncology
HSMN NewsFeed - 15 Sep 2006
Schering AG and AstraZeneca Form Strategic Alliance to Develop Novel Anti-Cancer Drug
Schering AG and AstraZeneca Form Strategic Alliance to Develop Novel Anti-Cancer Drug
HSMN NewsFeed - 14 Sep 2006
BioBalance Announces the Resignation of Its CEO and the Assumption of Additional Duties by Richard Serbin
BioBalance Announces the Resignation of Its CEO and the Assumption of Additional Duties by Richard Serbin
HSMN NewsFeed - 14 Sep 2006
Medivation Appoints Dr. Andrew A. Protter Vice President of Preclinical Development
Medivation Appoints Dr. Andrew A. Protter Vice President of Preclinical Development
HSMN NewsFeed - 14 Sep 2006
Amicus Therapeutics Raises $60 Million Series D Financing; Company Also Makes Two Key Executive Appointments
Amicus Therapeutics Raises $60 Million Series D Financing; Company Also Makes Two Key Executive Appointments
HSMN NewsFeed - 14 Sep 2006
Sara Zaknoen, M.D., Joins Cabrellis Pharmaceuticals as Chief Medical Officer
Sara Zaknoen, M.D., Joins Cabrellis Pharmaceuticals as Chief Medical Officer
HSMN NewsFeed - 14 Sep 2006
Study Shows Exenatide Improves Blood Sugar Levels as Effectively as Biphasic Insulin Aspart
Study Shows Exenatide Improves Blood Sugar Levels as Effectively as Biphasic Insulin Aspart
HSMN NewsFeed - 14 Sep 2006
Genmab Initiates HuMax-EGFr Pivotal Study In Refractory Head and Neck Cancer
Genmab Initiates HuMax-EGFr Pivotal Study In Refractory Head and Neck Cancer
HSMN NewsFeed - 13 Sep 2006
Watson and Unimed Pharmaceuticals, Inc. Settle Lawsuit Over AndroGel(R) Testosterone Gel
Watson and Unimed Pharmaceuticals, Inc. Settle Lawsuit Over AndroGel(R) Testosterone Gel
HSMN NewsFeed - 13 Sep 2006
Par Pharmaceutical Announces Agreement With Unimed Pharmaceuticals to Settle AndroGel(R) Patent Litigation
Par Pharmaceutical Announces Agreement With Unimed Pharmaceuticals to Settle AndroGel(R) Patent Litigation
HSMN NewsFeed - 13 Sep 2006
Heart Failure Patient Quality of Care Improves at Hospitals in the Get With The Guidelines(SM) Program
Heart Failure Patient Quality of Care Improves at Hospitals in the Get With The Guidelines(SM) Program
HSMN NewsFeed - 13 Sep 2006
Anthera Pharmaceuticals Secures $36M Venture Financing to Initiate Clinical Programs
Anthera Pharmaceuticals Secures $36M Venture Financing to Initiate Clinical Programs
HSMN NewsFeed - 12 Sep 2006
Elite Pharmaceuticals Provides Update on Company's Progress and Projected Milestones
Elite Pharmaceuticals Provides Update on Company's Progress and Projected Milestones
HSMN NewsFeed - 12 Sep 2006
Curis, Inc. Announces New Cancer Programs, Formation of China-Based Subsidiary
Curis, Inc. Announces New Cancer Programs, Formation of China-Based Subsidiary
HSMN NewsFeed - 12 Sep 2006
Icagen Reports Results of Data Monitoring Committee Meeting in Phase III Assert Trial of ICA-17043
Icagen Reports Results of Data Monitoring Committee Meeting in Phase III Assert Trial of ICA-17043
HSMN NewsFeed - 12 Sep 2006
Arena Pharmaceuticals Initiates Lorcaserin Phase 3 Obesity Clinical Trial
Arena Pharmaceuticals Initiates Lorcaserin Phase 3 Obesity Clinical Trial
HSMN NewsFeed - 12 Sep 2006
Biopure's Marketing Application for Hemopure(R) Accepted for Review In United Kingdom
Biopure's Marketing Application for Hemopure(R) Accepted for Review In United Kingdom
HSMN NewsFeed - 12 Sep 2006
Transition Therapeutics Appoints Andre Uddin B.Sc., Ph.D. as Vice-President of Strategic Development
Transition Therapeutics Appoints Andre Uddin B.Sc., Ph.D. as Vice-President of Strategic Development
HSMN NewsFeed - 11 Sep 2006
Statement from Dey, L.P. Regarding Pricing Litigation by the U.S. Department of Justice
Statement from Dey, L.P. Regarding Pricing Litigation by the U.S. Department of Justice
HSMN NewsFeed - 11 Sep 2006
Ranbaxy Receives FDA Approval to Market Loperamide Hydrochloride and Simethicone Tablets
Ranbaxy Receives FDA Approval to Market Loperamide Hydrochloride and Simethicone Tablets
HSMN NewsFeed - 11 Sep 2006
Perrigo Announces Joseph C. Papa as New CEO; David T. Gibbons to Remain as Chairman
Perrigo Announces Joseph C. Papa as New CEO; David T. Gibbons to Remain as Chairman
HSMN NewsFeed - 8 Sep 2006
Taro Announces Filing Of ANDA For Oxcarbazepine Tablets 150, 300 And 600 MG
Taro Announces Filing Of ANDA For Oxcarbazepine Tablets 150, 300 And 600 MG
HSMN NewsFeed - 8 Sep 2006
Shire Provides Update on U.S. Marketing Application of MESAVANCE(TM) (mesalamine) With MMX Technology
Shire Provides Update on U.S. Marketing Application of MESAVANCE(TM) (mesalamine) With MMX Technology
HSMN NewsFeed - 8 Sep 2006
Abraxis BioScience Names Leadership Team for Its Abraxis Pharmaceutical Products Division
Abraxis BioScience Names Leadership Team for Its Abraxis Pharmaceutical Products Division
HSMN NewsFeed - 7 Sep 2006
U.S. Court of Appeals Rules in Favor of Mylan in Oxybutynin Patent Litigation
U.S. Court of Appeals Rules in Favor of Mylan in Oxybutynin Patent Litigation
HSMN NewsFeed - 7 Sep 2006
Barr Launches a Generic Version of its SEASONALE(R) Extended-Cycle Oral Contraceptive
Barr Launches a Generic Version of its SEASONALE(R) Extended-Cycle Oral Contraceptive
HSMN NewsFeed - 7 Sep 2006
Celsion Announces Management Changes and Formation of Prolieve and Oncology Divisions
Celsion Announces Management Changes and Formation of Prolieve and Oncology Divisions
HSMN NewsFeed - 7 Sep 2006
Baxter Names Peter Nicklin Corporate Vice President and President, Baxter Europe
Baxter Names Peter Nicklin Corporate Vice President and President, Baxter Europe
HSMN NewsFeed - 7 Sep 2006
King Pharmaceuticals Announces Strategic Acquisition of Avinza(R) from Ligand Pharmaceuticals
King Pharmaceuticals Announces Strategic Acquisition of Avinza(R) from Ligand Pharmaceuticals
HSMN NewsFeed - 7 Sep 2006
Watson Pharmaceuticals Receives FDA Final Approval for Generic Seasonale(R)
Watson Pharmaceuticals Receives FDA Final Approval for Generic Seasonale(R)
HSMN NewsFeed - 7 Sep 2006
IMPAX Prevails in Alza's Appeal Related to Generic Version of Ditropan(R) XL
IMPAX Prevails in Alza's Appeal Related to Generic Version of Ditropan(R) XL
HSMN NewsFeed - 7 Sep 2006
GTx and Ipsen Enter Into Partnership Agreement for the European Rights of Acapodene(R)
GTx and Ipsen Enter Into Partnership Agreement for the European Rights of Acapodene(R)
HSMN NewsFeed - 7 Sep 2006
Ipsen and GTx Enter into Partnership Agreement for The European Rights of Acapodene(R)
Ipsen and GTx Enter into Partnership Agreement for The European Rights of Acapodene(R)
HSMN NewsFeed - 6 Sep 2006
Dynavax Establishes Collaboration for TLR-9 Agonists for Asthma and COPD With AstraZeneca
Dynavax Establishes Collaboration for TLR-9 Agonists for Asthma and COPD With AstraZeneca
HSMN NewsFeed - 6 Sep 2006
Genzyme Begins Phase 3 Pivotal Study of Clolar(R) in Adult Acute Myelogenous Leukemia
Genzyme Begins Phase 3 Pivotal Study of Clolar(R) in Adult Acute Myelogenous Leukemia
HSMN NewsFeed - 6 Sep 2006
Artisan Pharma, Inc. Raises $39 Million in a Series A Financing Led by NGN Capital LLC
Artisan Pharma, Inc. Raises $39 Million in a Series A Financing Led by NGN Capital LLC
HSMN NewsFeed - 6 Sep 2006
Xanthus Pharmaceuticals Licenses Novel Cancer Targeting Agents From Schering AG, Berlin
Xanthus Pharmaceuticals Licenses Novel Cancer Targeting Agents From Schering AG, Berlin
